Given the differences in CSF apoE aggregates found under native conditions between AD and controls, we evaluated the levels of the 34-kDa, 36-kDa, and 100-kDa apoE species by SDS-PAGE in reducing conditions and western blotting, using the AB178479 antibody (Fig. 4A). The gene discussed is APOE; the disease is Alzheimer disease.